Monitoring the ex-vivo expansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy

被引:9
|
作者
Rosa, Filipa [1 ]
Sales, Kevin C. [1 ]
Carmelo, Joana G. [2 ,3 ]
Fernandes-Platzgummer, Ana [2 ,3 ]
da Silva, Claudia L. [2 ,3 ]
Lopes, Marta B. [4 ,5 ]
Calado, Cecilia R. C. [4 ]
机构
[1] Catholic Univ Portugal, Fac Engn, Rio De Mouro, Portugal
[2] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Ave Rovisco Pais, P-1049001 Lisbon, Portugal
[3] Univ Lisbon, Inst Super Tecn, iBB, Ave Rovisco Pais, P-1049001 Lisbon, Portugal
[4] ISEL, Rua Conselheiroidio Emidio Navarro 1, P-1959007 Lisbon, Portugal
[5] Inst Super Tecn, Inst Telecommun, Ave Rovisco Pais, P-1049001 Lisbon, Portugal
关键词
mesenchymal stem; stromal cells; MIR spectroscopy; high-throughput analysis; NEAR-INFRARED SPECTROSCOPY; STEM-CELLS; BONE-MARROW; CULTURE-SYSTEM; METABOLISM; CHEMOMETRICS; CULTIVATION; PREDICTION; MODELS; NIR;
D O I
10.1002/btpr.2215
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human mesenchymal stem/stromal cells (MSCs) have received considerable attention in the field of cell-based therapies due to their high differentiation potential and ability to modulate immune responses. However, since these cells can only be isolated in very low quantities, successful realization of these therapies requires MSCs ex-vivo expansion to achieve relevant cell doses. The metabolic activity is one of the parameters often monitored during MSCs cultivation by using expensive multi-analytical methods, some of them time-consuming. The present work evaluates the use of mid-infrared (MIR) spectroscopy, through rapid and economic high-throughput analyses associated to multivariate data analysis, to monitor three different MSCs cultivation runs conducted in spinner flasks, under xeno-free culture conditions, which differ in the type of microcarriers used and the culture feeding strategy applied. After evaluating diverse spectral preprocessing techniques, the optimized partial least square (PLS) regression models based on the MIR spectra to estimate the glucose, lactate and ammonia concentrations yielded high coefficients of determination (R(2)0.98, 0.98, and 0.94, respectively) and low prediction errors (RMSECV4.7%, 4.4% and 5.7%, respectively). Besides PLS models valid for specific expansion protocols, a robust model simultaneously valid for the three processes was also built for predicting glucose, lactate and ammonia, yielding a R-2 of 0.95, 0.97 and 0.86, and a RMSECV of 0.33, 0.57, and 0.09 mM, respectively. Therefore, MIR spectroscopy combined with multivariate data analysis represents a promising tool for both optimization and control of MSCs expansion processes. (c) 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:447-455, 2016
引用
收藏
页码:447 / 455
页数:9
相关论文
共 50 条
  • [31] Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture
    Yuan, Yifan
    Kallos, Michael S.
    Hunter, Christopher
    Sen, Arindom
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 (03) : 210 - 225
  • [32] Scalable Production of Human Mesenchymal Stromal Cell (MSC)-Derived Extracellular Vesicles in Microcarrier-based Bioreactors under Xeno(geneic)-free Conditions
    Fuzeta, M. A.
    Oliveira, F. D.
    Costa, A. C.
    Fernandes-Platzgummer, A.
    Jung, S.
    Tseng, R.
    Milligan, W.
    Lee, B.
    Bernardes, N.
    Gaspar, D.
    Cabral, J. M.
    da Silva, C. L.
    CYTOTHERAPY, 2020, 22 (05) : S23 - S24
  • [33] COST EFFECTIVE, SINGLE-USE SOLUTION FOR EXPANSION OF HUMAN MESENCHYMAL STEM CELLS IN XENO-FREE MEDIUM
    Szczypka, M. S.
    Soder, R. P.
    Splan, D.
    CYTOTHERAPY, 2023, 25 (06) : S94 - S94
  • [34] Xeno-Free Production of Human Embryonic Stem Cells in Stirred Microcarrier Systems Using a Novel Animal/Human-Component-Free Medium
    Nobrega Marinho, Paulo Andre
    Vareschini, Daniel Tait
    Gomes, Ismael Carlos
    Paulsen, Bruna da Silveira
    Furtado, Daniel Rodrigues
    Castilho, Leda dos Reis
    Rehen, Stevens Kastrup
    TISSUE ENGINEERING PART C-METHODS, 2013, 19 (02) : 146 - 155
  • [35] Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems
    Badenes, Sara M.
    Fernandes, Tiago G.
    Rodrigues, Carlos A. V.
    Diogo, Maria Margarida
    Cabral, Joaquim M. S.
    JOURNAL OF BIOTECHNOLOGY, 2016, 234 : 71 - 82
  • [36] Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems
    Badenes, Sara M.
    Fernandes, Tiago G.
    Cordeiro, Claudia S. M.
    Boucher, Shayne
    Kuninger, David
    Vemuri, Mohan C.
    Diogo, Maria Margarida
    Cabral, Joaquim M. S.
    PLOS ONE, 2016, 11 (03):
  • [37] To study the characteristics of human bone marrow mesenchymal stem cells during ex-vivo expansion
    Xia, W-J
    Fu, Y-S
    Xin, Ye Y.
    Ding, H-Q
    Luo, G-P
    Chen, Y-K
    Deng, J.
    VOX SANGUINIS, 2008, 95 : 251 - 252
  • [38] Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future
    Astori, Giuseppe
    Amati, Eliana
    Bambi, Franco
    Bernardi, Martina
    Chieregato, Katia
    Schaefer, Richard
    Sella, Sabrina
    Rodeghiero, Francesco
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [39] Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells
    Barro, Lassina
    Nebie, Ouada
    Chen, Ming-Sheng
    Wu, Yu-Wen
    Koh, Mickey B. C.
    Knutson, Folke
    Watanabe, Naoto
    Takahara, Masayasu
    Burnouf, Thierry
    CYTOTHERAPY, 2020, 22 (08) : 458 - 472
  • [40] Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future
    Giuseppe Astori
    Eliana Amati
    Franco Bambi
    Martina Bernardi
    Katia Chieregato
    Richard Schäfer
    Sabrina Sella
    Francesco Rodeghiero
    Stem Cell Research & Therapy, 7